DRUG · Unmapped registry intervention
MT-8421
Find medicine records ·
Find other trials using this name
Clinical trial
Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types
NCT06034860
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Nivolumab
Normalized identity: nivolumabView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Melanomaverified · MONDO: melanoma
Microsatellite Instability Highunresolved
Mismatch Repair Deficiencyunresolved
Mesotheliomaverified · MONDO: mesothelioma
Cervical Cancerverified · MONDO: cervical cancer
Interventions
MT-8421DRUG
NivolumabDRUG · verified · RxNorm: nivolumab
Sponsors & collaborators
Molecular Templates, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06034860 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.